Grip, you are wrong again. CytoSorbents (CTSO), a stock that I have owned and traded for ten years, is an American company that is approved in 52 countries for many years, including the U.K., and the E.U., but still has not received FDA approval for open use (just recently got approved EUA in U.S for CV). Other countries WILL certainly upstage "the other," as they will do what is in their best interest. Refute that fact! You are out of your element here.
The healthcare system of the UK is entirely independent of the FDA. It has entirely different considerations for how they approve drugs. They are far less archaic in terms of gauging if a drug is useful. The major hang up is that after approval comes the process of agreeing to drugs costs and how reimbursement will happen.
The idea that the UK would wait on the US to make a move, especially during a pandemic and in this political climate is absolutely absurd.
There are multiple instances of the UK acting independently of the United States on policy before. Nothing has changed to make them operate in lockstep.
Grip- The other day Dr. Gottlieb on CNBC said the EU is not likely to overstep the FDA . Even so "EMERGENCY USE" is not blanket approval. Sure it'll get a pop if they get the nod. But not today, not next week, maybe in 1-2 months. In the meanwhile the market has nothing to build a case on and should the technicals indicate, a resumption of the "TREND DOWN" will commence.
$3.00 may well be a good time to look again. But for those going for the round trip as I cautioned, the ride won't be pleasant.
Trying to help the helpless is futile. I post what I see. I'm not in the goodie goodie camp.
News 
Market Data 
Discover 
AI
